Medicinal Chemistry ChemMedChem (Wiley)
Halogens on the thiazolide core fix solubility and clearance in antiviral leads
- Earlier thiazolide leads against HBV, HCV and influenza A were held back by poor solubility and fast metabolic clearance, so the authors made halogenated and 4'-alkylsulfone analogs.
- A 3-position halogen improved solubility and metabolic stability together, with two chlorothiazolides keeping influenza A activity and acceptable safety margins.
- In the sulfone series, short two- to three-carbon chains worked best, yielding three leads for in vivo work.
A halogen improving solubility is the surprising part, since it usually adds lipophilicity. I'd want logD and melting point to see whether this is lower crystal packing or a phenol pKa shift, and whether the gain in stability is blocked glucuronidation. Also, if the nitrothiazole is retained, nitroreduction liability still needs an Ames check before in vivo.
Paper: ChemMedChem (Wiley) ↗ Defining the Structure–Activity Relationships of Thiazolide Antivirals: Balancing Potency, Metabolic Stability, and Aqueous Solubility